KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Buildings (2023 - 2025)

Edwards Lifesciences (EW) has 3 years of Buildings data on record, last reported at $1.4 billion in Q4 2025.

  • For Q4 2025, Buildings rose 3.99% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, up 3.99%, while the annual FY2025 figure was $1.4 billion, 3.99% up from the prior year.
  • Buildings reached $1.4 billion in Q4 2025 per EW's latest filing, up from $1.3 billion in the prior quarter.
  • Across five years, Buildings topped out at $1.4 billion in Q4 2025 and bottomed at $1.2 billion in Q4 2023.
  • Average Buildings over 3 years is $1.3 billion, with a median of $1.3 billion recorded in 2024.
  • Peak YoY movement for Buildings: increased 12.68% in 2024, then rose 3.99% in 2025.
  • A 3-year view of Buildings shows it stood at $1.2 billion in 2023, then increased by 12.68% to $1.3 billion in 2024, then rose by 3.99% to $1.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Buildings were $1.4 billion in Q4 2025, $1.3 billion in Q4 2024, and $1.2 billion in Q4 2023.